yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q38282461-1DDF6B83-6972-47E3-B744-922DC0E94CA5
Q38282461-1DDF6B83-6972-47E3-B744-922DC0E94CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38282461-1DDF6B83-6972-47E3-B744-922DC0E94CA5
Advances in systemic therapies for metastatic castration-resistant prostate cancer.
P2860
Q38282461-1DDF6B83-6972-47E3-B744-922DC0E94CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38282461-1DDF6B83-6972-47E3-B744-922DC0E94CA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
91cfe916c8f41374bfe8be759ae9c9deca55a6f4
P2860
Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer.